New insider activity at Boston Scientific ( (BSX) ) has taken place on May 30, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Director Edward Ludwig has recently sold 4,000 shares of Boston Scientific stock, amounting to a total transaction value of $418,360.
Spark’s Take on BSX Stock
According to Spark, TipRanks’ AI Analyst, BSX is a Outperform.
Boston Scientific’s strong financial performance and positive earnings call are significant strengths, supporting its strategic growth initiatives. However, the high valuation and recent product discontinuation pose risks. Technical indicators show stable momentum, but valuation concerns may limit upside potential.
To see Spark’s full report on BSX stock, click here.
More about Boston Scientific
YTD Price Performance: 16.92%
Average Trading Volume: 8,347,738
Technical Sentiment Signal: Buy
Current Market Cap: $154.6B